Other headlinesAccelaRAD extends client baseCarestream readies laser imager
MR maverick dodges Nasdaq bullet
Fonar has until Oct. 5 to prove to the Nasdaq exchange that the company has at least $500,000 in net income for the fiscal year ending June 30, 2009. The deadline was set by Nasdaq Listing and Hearing Review Council, which determined on June 24 that the maker of MR scanners can remain listed on the exchange until that time. Fonar has reported net income of more than $1 million for the first nine months of the current fiscal year.
AccelaRAD extends client base
IT network specialist AccelaRAD announced June 26 the installation of advanced digital management software at five new sites. Three are Mid-Atlantic Unified Health System-affiliated imaging centers, which are using AccelaRAD’s Virtual Radiology Network to provide PACS functionality, offsite archiving, and sophisticated online communication with referring physicians. The other two are using the network to provide remote access to images for offsite radiology reading groups.
Carestream readies laser imager
The FDA has cleared a tabletop laser imager from Carestream Health designed for digital mammography and general radiography. Shipments in the U.S. and other countries are set to begin immediately. The new laser imager, dubbed DRYVIEW 5850, offers 508 pixels-per-inch output. Two on-line film trays support DICOM printing of general radiography and mammography from both full-field digital and computed radiography systems.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.